JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strauss, L. G.
Right arrow Articles by Thiesen, H.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strauss, L. G.
Right arrow Articles by Thiesen, H.-J.

18F-FDG Kinetics and Gene Expression in Giant Cell Tumors

Ludwig G. Strauss, MD1, Antonia Dimitrakopoulou-Strauss, MD1, Dirk Koczan, PhD2, Ludger Bernd, MD3, Uwe Haberkorn, MD1, Volker Ewerbeck, MD3 and Hans-Jürgen Thiesen, MD2

1 Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany
2 Institute of Immunology, University Rostock, Rostock, Germany
3 Department I, University Orthopedic Clinic, Heidelberg, Germany



View larger version (88K):

[in a new window]
 
FIGURE 1. Gene chip data for 5 giant cell tumors. Normalized expression values are presented in descending order. Data are sorted according to median gene expression values for 5 tumor specimens. Three of the genes with high expression values are shown in bold type (small proteoglycan I, Wilms’ tumor-related protein, and RhoA). Cluster analysis was applied to the data and revealed 2 subgroups, consisting of 2 tumors (left 2 columns) and 3 tumors (right 3 columns).

 


View larger version (11K):

[in a new window]
 
FIGURE 2. (A) Correlation of SUV with VEGF-A expression (r = 0.9618; P = 0.0089). (B) Correlation of SUV with Cdc2 expression (r = 0.9392; P = 0.0178).

 


View larger version (9K):

[in a new window]
 
FIGURE 3. (A) Correlation of vessel density (VB) with VEGF-B (r = 0.8716; P = 0.0541). (B) Correlation of vessel density (VB) with cyclin E (r = 0.9885; P = 0.0015).

 


View larger version (10K):

[in a new window]
 
FIGURE 4. (A) Correlation of k3 with sFLT (r = 0.9444; P = 0.0156). (B) Correlation of k3 with HIF-1 (r = 0.9738; P = 0.0051).

 


View larger version (9K):

[in a new window]
 
FIGURE 5. Correlation of fractal dimension (FD) with VEGF-A (r = 0.9707; P = 0.0060).

 


View larger version (21K):

[in a new window]
 
FIGURE 6. Comparison of 2 giant cell tumors with low 18F-FDG uptake and high 18F-FDG uptake. Both images are scaled to the same range (SUV, 0–5.8). (Upper image) Giant cell tumor of right tibia with an 18F-FDG SUV of 2.4. The relative expression value for VEGF-A was 81. (Lower image) Giant cell tumor of left tibia with an 18F-FDG SUV of 5.8. The relative expression value for VEGF-A was 240.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.